Lessing’s 5K raised hope for families facing rare disease
Lessing’s Hospitality Group’s 35th annual 5K in Babylon raised funds for the National MPS Society, celebrating the FDA approval of Ultragenyx's gene therapy for MPS IIIA. The event recognizes families affected by this rare disease and highlights decades of community support advancing treatment options.
Lessing’s Hospitality Group’s 35th annual 5K in Babylon raised funds for the National MPS Society, celebrating the FDA approval of Ultragenyx's gene therapy for MPS IIIA. The event recognizes families affected by this rare disease and highlights decades of community support advancing treatment options.
What's Your Reaction?
